Issue 6, 2021

A cage-based covalent organic framework for drug delivery

Abstract

A novel cage-based crystalline covalent organic framework, i.e. Cage-COF-TT (TT = triammonia–terephthalaldehyde), was prepared from a prism-like triammonia-containing molecular cage and terephthalaldehyde. Its ordered structure and porosity are expected to ensure efficient drug delivery as a potent carrier. The excellent cell viability of Cage-COF-TT was testified through MTT assays with respect to both normal mouse cells and normal human hepatocyte cells. In terms of drug delivery performance, Cage-COF-TT exhibit a high loading capacity and efficient drug release profile in a simulated body fluid environment. This work offers new insights into the design and development of a COF-based drug carrier and inspires the development of versatile tools for biomedical applications.

Graphical abstract: A cage-based covalent organic framework for drug delivery

Supplementary files

Article information

Article type
Paper
Submitted
08 Oct 2020
Accepted
11 Dec 2020
First published
15 Dec 2020

New J. Chem., 2021,45, 3343-3348

A cage-based covalent organic framework for drug delivery

M. Li, Y. Peng, F. Yan, C. Li, Y. He, Y. Lou, D. Ma, Y. Li, Z. Shi and S. Feng, New J. Chem., 2021, 45, 3343 DOI: 10.1039/D0NJ04941G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements